Atropine SulfateInjection, USP

Preservative-free
Vial closure is not made with natural rubber latex
This drug product is not FDA-approved
These marketed unapproved Atropine products have been replaced with NDC 0157-1004-25 and 0517-1001-25. All future orders will be filled with FDA-approved Atropine NDC 0517-1004-25 and 0517-1001-25. Marketed unapproved Atropine (NDC 0517-0401-25 and 05171010-25) can remain in your inventory. There is no need to return the product, and they are suitable for use through expiry unless a situation arises to warrant a return.

For more information on FDA-approved Atropine Sulfate Injection, USP click here.

	Pack NDC#	Strength	Supplied As	Shelf Pack	Vial Opening Size	Product Info	Availability
	Strength: 0.4 mg/mL Supplied As: 1 mL Single Dose Vial NDC#: 0517-0401-25	0517-0401-25	0.4 mg/mL	1 mL Single Dose Vial	25	13 mm	Product Label Full Prescribing Information Safety Data Sheet	Discontinued
Shelf Pack 25 Availability Discontinued Product Label Full Prescribing Information Safety Data Sheet Wholesaler Numbers ABC/SAP 10036544 Cardinal 1467331 McKesson 1730464 Morris & Dickson 076695 Case Information Unit of Sale NDC 0401-25 Order Size 25 Case Size 40 Case Per Tier 108 Locate Distributor Receive Availability Emails
	Strength: 1 mg/mL Supplied As: 1 mL Single Dose Vial NDC#: 0517-1010-25	0517-1010-25	1 mg/mL	1 mL Single Dose Vial	25	13 mm	Product Label Full Prescribing Information Safety Data Sheet	Discontinued
Shelf Pack 25 Availability Discontinued Product Label Full Prescribing Information Safety Data Sheet Wholesaler Numbers ABC/SAP 10036546 Cardinal 1467349 McKesson 3210242 Morris & Dickson 31955 Case Information Unit of Sale NDC 1010-25 Order Size 25 Case Size 20 Case Per Tier 198 Locate Distributor Receive Availability Emails

View Our Sales and Return Policy

Contact Us

Request for Medical Information Request a Grant Investigator Initiated Study Request a Certificate of Analysis Expanded Access Policy

P: 800-645-1706
(8:00am–6pm Monday - Thursday and Friday 8:00am–4pm Eastern Time)
P: 800-734-9236
F: 610-650-0170
E: pv@americanregent.com

Adverse Drug Events (ADEs) may be reported to the FDA:
Phone: 1-800-FDA-1088
Web: www.fda.gov/medwatch
P: 888-354-4859
E: pqc@americanregent.com
P: 888-354-4855
(9am–5pm Eastern Time, Monday - Friday)
E: ma@americanregent.com

For drug information outside of normal business hours that cannot wait until the next day, please call:

P: 877-845-6371
American Regent, Inc.
5 Ramsey Road
Shirley, NY 11967

P: 631-924-4000
F: 631-924-1731

Find a Distributor

Please choose your preferred method of contact

By clicking Submit, you confirm that you accept our Privacy Policy and that you agree to your personal contact information being used to contact you and added to our database. If at any time you wish your personal information to be removed from the American Regent^® database, please submit a message request to corpcommunications@americanregent.com.